We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$889M
AUM Growth
-$44.7M
Cap. Flow
-$35.9M
Cap. Flow %
-4.04%
Top 10 Hldgs %
38.81%
Holding
235
New
39
Increased
42
Reduced
20
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 15.73%
2 Healthcare 15.15%
3 Industrials 14.43%
4 Financials 13.07%
5 Consumer Discretionary 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSEAW
151
DELISTED
Landsea Homes Corporation Warrant
LSEAW
$143K 0.02%
447,993
VTIQW
152
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
$140K 0.02%
279,200
EVH icon
153
Evolent Health
EVH
$444M
$134K 0.02%
18,700
+3,200
+21% +$23K
CTACW
154
DELISTED
ChaSerg Technology Acquisition Corp. Warrant
CTACW
$132K 0.01%
147,768
ROAN
155
DELISTED
Roan Resources, Inc.
ROAN
$130K 0.01%
105,550
ASLEW
156
DELISTED
AerSale Corp Warrants
ASLEW
$128K 0.01%
284,300
VEON icon
157
VEON
VEON
$3.87B
$101K 0.01%
1,680
+560
+50% +$38.4K
NEBUW
158
DELISTED
Nebula Acquisition Corporation Warrant
NEBUW
$93K 0.01%
93,031
ANDAR
159
DELISTED
Andina Acquisition Corp. III Right
ANDAR
$73K 0.01%
243,600
GNT
160
GAMCO Natural Resources, Gold & Income Trust
GNT
$147M
$72K 0.01%
12,664
+316
+3% +$1.83K
TKKSR
161
DELISTED
TKK Symphony Acquisition Corporation Right
TKKSR
$50K 0.01%
208,580
RVPHW
162
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$49K 0.01%
194,500
SNAXW
163
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$49K 0.01%
243,600
BRPM.WS
164
DELISTED
B. Riley Principal Merger Corp. Warrants, each whole warrant exercisable for one share of Class A co
BRPM.WS
$46K 0.01%
100,150
TRNE.WS
165
DELISTED
Trine Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A
TRNE.WS
$39K ﹤0.01%
49,500
INAP
166
DELISTED
Internap Corporation
INAP
$26K ﹤0.01%
10,000
OPK icon
167
Opko Health
OPK
$1.04B
$21K ﹤0.01%
10,000
-10,000
-50% -$20.4K
TKKSW
168
DELISTED
TKK Symphony Acquisition Corporation Warrant
TKKSW
$19K ﹤0.01%
208,580
CHR icon
169
Cheer Holding
CHR
$3.61M
-222
Closed -$3.33M
CI icon
170
Cigna
CI
$73.6B
-1,300
Closed -$205K
ELV icon
171
Elevance Health
ELV
$86.2B
-750
Closed -$212K
EXAS
172
DELISTED
Exact Sciences
EXAS
-4,356
Closed -$514K
HOFV
173
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
-24,151
Closed -$3.86M
HON icon
174
Honeywell
HON
$77B
-1,273
Closed -$210K
NWL icon
175
Newell Brands
NWL
$2.51B
-12,000
Closed -$185K

Similar funds

Gabelli & Co Investment Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Gabelli & Co Investment Advisers held 235 positions worth $889M, down 4.8% from $933M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $35.9M in Q3 2019, closing 50 positions and reducing 20 holdings. Its most notable exit was Red Hat Inc, an estimated $52.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Genesee & Wyoming Inc. worth $19.6M.

  • Gabelli & Co Investment Advisers's largest Q3 2019 buy was Genesee & Wyoming Inc.: 177,094 shares worth $19.6M.
  • Gabelli & Co Investment Advisers added most to Altaba Inc in Q3 2019, an estimated $27.4M increase.
  • Gabelli & Co Investment Advisers's biggest Q3 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $3.23M.
  • Gabelli & Co Investment Advisers fully exited Red Hat Inc in Q3 2019, selling an estimated $52.2M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 39% of its $889M portfolio in Q3 2019.
  • Gabelli & Co Investment Advisers opened 39 new positions and closed 50 in Q3 2019.
  • Gabelli & Co Investment Advisers's portfolio value fell 4.8% quarter-over-quarter to $889M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2019, filed 1 Nov 2019.